Inhibition of interleukin-2-induced T-cell proliferation by sera from patients with the acquired immune deficiency syndrome
- PMID: 3007564
- DOI: 10.1007/BF00915369
Inhibition of interleukin-2-induced T-cell proliferation by sera from patients with the acquired immune deficiency syndrome
Abstract
Sera from 22 patients with either lymphadenopathy syndrome (LAS), acquired immune deficiency syndrome (AIDS)-related complex (ARC), or acquired immune deficiency syndrome were examined for their effect on the interleukin-2 (IL-2)-induced proliferative response of an IL-2-dependent cytotoxic T-cell line, CTL-20. All of the patient sera included in this study were positive for the presence of antibodies against human T-cell lymphotropic virus type III (HTLV-III) as determined by an HTLV-III-specific enzyme-linked immunosorbent assay (ELISA). Eighteen of the 22 patient sera examined (81.8%) exhibited at least a modest suppressive effect on the proliferative response of CTL-20 cells. The inhibitory effect was dose-dependent and varied in intensity for each individual serum. In many cases, the magnitude of suppression was absolute in that it totally abrogated IL-2-induced DNA synthesis. Normal human serum (NHS) exerted no suppressive influence on the IL-2-induced proliferative response of identical control cultures. This same panel of 22 patient sera exhibited no significant inhibitory effects on the levels of protein synthesis in cultures of a non-IL-2-dependent human T-cell line, CCRF-HSB-2, indicating that the suppressive effect was not mediated by nonspecific serum cytotoxicity. The inhibitory effect of patient sera in the IL-2-dependent target cell assay correlated with the ability of these same sera to suppress the mitogen-induced proliferative response of normal human peripheral blood lymphocytes (PBL). These observations are particularly striking in view of the recognized defects of IL-2-dependent effector T-cell functions in AIDS.
Similar articles
-
Humoral-mediated suppression of interleukin 2-dependent target cell proliferation in acquired immune deficiency syndrome (AIDS): interference with normal IL-2 receptor expression.Clin Exp Immunol. 1987 Jun;68(3):488-99. Clin Exp Immunol. 1987. PMID: 3115647 Free PMC article.
-
Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.J Clin Invest. 1985 Oct;76(4):1699-704. doi: 10.1172/JCI112158. J Clin Invest. 1985. PMID: 2997287 Free PMC article.
-
A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).J Immunol. 1986 Oct 15;137(8):2514-21. J Immunol. 1986. PMID: 3489767
-
Immunopathogenesis of the acquired immunodeficiency syndrome.Ann Intern Med. 1985 Nov;103(5):704-9. doi: 10.7326/0003-4819-103-5-704. Ann Intern Med. 1985. PMID: 2996403 Review.
-
Human T-cell leukemia virus: its discovery and role in leukemogenesis and immunosuppression.Adv Intern Med. 1984;30:1-27. Adv Intern Med. 1984. PMID: 6084947 Review.
Cited by
-
Specificity of anti-lymphocyte antibodies in sera from patients with AIDS-related complex (ARC) and healthy homosexuals.Clin Exp Immunol. 1988 Aug;73(2):168-73. Clin Exp Immunol. 1988. PMID: 3052941 Free PMC article.
-
Reversal of immunosuppression of lymphocyte proliferation caused by sera from persons with AIDS.Clin Diagn Lab Immunol. 1995 Jul;2(4):408-11. doi: 10.1128/cdli.2.4.408-411.1995. Clin Diagn Lab Immunol. 1995. PMID: 7583915 Free PMC article.
-
Humoral-mediated suppression of interleukin 2-dependent target cell proliferation in acquired immune deficiency syndrome (AIDS): interference with normal IL-2 receptor expression.Clin Exp Immunol. 1987 Jun;68(3):488-99. Clin Exp Immunol. 1987. PMID: 3115647 Free PMC article.
-
Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.Drugs. 1987 Sep;34(3):372-90. doi: 10.2165/00003495-198734030-00004. Drugs. 1987. PMID: 2824170 Review.
-
Soluble Il-2 receptor serum levels--a marker for disease progression in patients with HIV-1 infection.Arch Dermatol Res. 1989;281(5):299-303. doi: 10.1007/BF00412971. Arch Dermatol Res. 1989. PMID: 2802661
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical